Stephen B. H. Kent
Corporate Officer/Principal chez The University of Chicago
Postes actifs de Stephen B. H. Kent
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01/01/2001 | - |
| Victoria University of Wellington | Corporate Officer/Principal | 01/01/2004 | - |
Historique de carrière de Stephen B. H. Kent
Anciens postes connus de Stephen B. H. Kent
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Directeur Technique/Scientifique/R&D | 01/01/1994 | 01/01/2002 |
| Fondateur | 01/01/1994 | 01/01/2002 | |
Ciphergen Biosystems KK
 Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Ciphergen Biosystems KK markets and supplies protein chip systems and services for clinical, research and process proteomic applications. The company was founded in January, 1999 and is headquartered in Yokohama, Japan. | Directeur/Membre du Conseil | 01/01/1994 | 01/01/1997 |
Opal Therapeutics Pty Ltd.
 Opal Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Opal Therapeutics Pty Ltd develops immunotherapy for HIV and Hepatitis C & chronic infection. The company was founded in 2005 and is headquartered in Melbourne, Australia. | Fondateur | - | - |
| Corporate Officer/Principal | 03/06/2011 | - | |
| ENZO BIOCHEM, INC. | Directeur/Membre du Conseil | 01/01/2007 | - |
| Independent Dir/Board Member | 01/01/2007 | - |
Formation de Stephen B. H. Kent
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Japon | 2 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Ciphergen Biosystems KK
Ciphergen Biosystems KK Electronic Equipment/InstrumentsElectronic Technology Ciphergen Biosystems KK markets and supplies protein chip systems and services for clinical, research and process proteomic applications. The company was founded in January, 1999 and is headquartered in Yokohama, Japan. | Electronic Technology |
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Health Technology |
Opal Therapeutics Pty Ltd.
Opal Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Opal Therapeutics Pty Ltd develops immunotherapy for HIV and Hepatitis C & chronic infection. The company was founded in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
- Bourse
- Insiders
- Stephen B. H. Kent
- Expérience
